CARsgen Therapeutics Holdings Limited (Stock Code: 2171), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that the first ...

Trenchant partnered with Autolomous, integrating its digital solution into its CGT manufacturing platform, for faster production and lower costs.

Cells navigating in complex microenvironments frequently encounter narrow spaces that physically challenge migration.

The world of aesthetic tweakments is no longer dominated by muscle-relaxing injections and filler. No, no; these days, there ...

NMN supplements promise a whole lot, you see, including age-defying properties, boosted energy, enhanced metabolism, and ...

Following a healthy diet is essential in preventing and fighting cancer, but research now says the way you eat could play a ...

The company dropped a HER2xCD3 bispecific RG6194 (runimotamab), which was being developed for breast cancer, and an IL-15 based immunotherapy efbalropendekin alfa, which was designed to stimulate T ...

The Phase III trial builds on findings from prior findings that indicated Anktiva can restore T-cell function and improve ...

Dr. Baker added,“Artiva is pioneering novel NK cell therapies with unmatched versatility and broad expansion potential across autoimmune diseases. I look forward to partnering with the management team ...

Research shows that long-term exposure to polluted air is linked to respiratory and cardiovascular diseases, so the cleaner ...

The owner of the Los Angeles Times discusses his fight to cure cancer and why he wants President Donald Trump to succeed in ...

This important study provides solid evidence to support the anti-tumor potential of citalopram, originally an anti-depression drug, in hepatocellular carcinoma (HCC). In addition to their previous ...